Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Huzhou Shengtai Biotech is a biotechnology company focused on the development and manufacture of high-quality enzymes and raw materials for the in vitro diagnostics (IVD) industry. The company specializes in protein expression and purification, providing a variety of diagnostic enzymes such as uricase, sarcosine oxidase, and creatinine amidohydrolase. These products are essential components for clinical chemistry reagents used in monitoring metabolic and renal functions. Based in Huzhou, China, the firm supports diagnostic kit manufacturers with bulk reagents and customized biological solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Huzhou Shengtai Biotech.